Business Context and Reporting Period
This Form 6-K filing by Intercure Ltd. (dba Canndoc) covers the month of December 2025, with the report dated December 18, 2025. The filing discloses a material event involving the Company's key service provider, the Bazelet group of companies, which has initiated restructuring proceedings before the Israeli District Court, including an application for a temporary stay of proceedings.
Key Financial Metrics
The filing does not provide standard financial performance metrics such as revenue, profit, cash flow, margins, or overall debt levels. However, it discloses a specific exposure related to the Bazelet restructuring:
- Outstanding Receivables: The Company holds checks issued by Bazelet in an aggregate amount of approximately NIS 27 million.
- Status: These checks remain outstanding during the stay of proceedings.
Material Changes
The primary material change is the initiation of restructuring proceedings by Bazelet, a leading producer of cannabis oil and a critical service provider for Intercure. Bazelet provides production, EU-GMP-certified export, and distribution services in the Israeli market and occasionally purchases raw materials and products from Intercure. The restructuring and stay of proceedings create immediate uncertainty regarding the collection of the NIS 27 million in outstanding checks and the continuity of these essential services.
Outlook, Management Commentary, and Risks
Management is actively monitoring the court filings and, per Board of Directors' instructions, plans to pursue appropriate legal actions to protect its rights and interests. The Company is also evaluating collaboration with an additional packaging facility to mitigate operational disruptions. The filing includes standard forward-looking statements warning that actual results may differ due to risks including the outcome of Bazelet's restructuring, the availability of alternative service providers, and changes in the regulatory landscape for cannabis.
Investor Verification Checklist
- Verify the current status of the NIS 27 million in outstanding checks held from Bazelet.
- Confirm the timeline and outcome of the temporary stay of proceedings in the Israeli District Court.
- Assess the progress of Intercure's search for alternative packaging and production facilities.
- Review the potential impact of Bazelet's restructuring on Intercure's Israeli market distribution capabilities.